Safety and efficacy of camrelizumab combined with radiotherapy as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: a prospective single-arm phase II clinical trial protocol

BACKGROUND: Neoadjuvant chemoradiotherapy followed by esophagectomy is the standard of care for locally advanced esophageal squamous cell carcinoma (ESCC). However, approximately 30% of patients still develop distant metastases and have a high incidence of treatment-related adverse events. Immunothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Maohui, Huang, Yizhou, Zhang, Shuliang, Zeng, Taidui, Huang, Guanglei, Chen, Chun, Zheng, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463929/
https://www.ncbi.nlm.nih.gov/pubmed/37626367
http://dx.doi.org/10.1186/s13063-023-07534-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463929/
https://www.ncbi.nlm.nih.gov/pubmed/37626367
http://dx.doi.org/10.1186/s13063-023-07534-3

Ejemplares similares